beta
ARGS
Argos Therapeutics Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.
Market Cap: 509 Thousand
Primary Exchange: NASDAQ Capital Market
Website: http://www.argostherapeutics.com
Shares Outstanding: 221 Thousand
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.872818
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1046 trading days
From: 2014-03-06 To: 2018-04-24
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2018-01-19 | 20.0 | 1.0 | 20.0 |